Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Seven Fleet Capital Management LP
Form 13F · Q2 2026

Seven Fleet Capital Management LP

CIK 2092021Filed 2026-08-1713F-HR View the filing on EDGAR ↗
$606M
Reported book value
114
Positions
3
Quarters on record
Top 50
Positions

Seven Fleet Capital Management LP — holdings

Top 50 positions of 114, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1CGON Cg Oncology Inc1.9M+2389.8%$134M22.1%
2TNGX Tango Therapeutics Inc3.2M+543.0%$96M15.8%
3RVMD Revolution Medicines Inc242,029+199.6%$45M7.5%
4PHVS Pharvaris N V774,501+348.4%$27M4.4%
5LQDA Liquidia Corporation256,603+36.6%$20M3.4%
6ELVN Enliven Therapeutics Inc365,386+122.8%$19M3.1%
7ABIVAX SA Abivax Sa111,334+158.6%$15M2.4%
8AVTX Avalo Therapeutics Inc770,765+260.5%$14M2.4%
9MIRM Mirum Pharmaceuticals Inc110,393—$13M2.1%
10ASMB Assembly Biosciences Inc433,147+671.5%$12M2.0%
11IPSC Century Therapeutics Inc4.3M+47.5%$11M1.8%
12CYTK Cytokinetics Inc118,240+93.0%$10M1.7%
13TSHA Taysha Gene Therapies Inc1.5M+140.4%$10M1.6%
14MANE Veradermics Inc80,000—$10M1.6%
15AVBP Arrivent Biopharma Inc246,606+390.7%$9M1.4%
16TARS Tarsus Pharmaceuticals Inc117,067+491.2%$8M1.3%
17XNCR Xencor Inc368,305+360.4%$8M1.3%
18ROIV Roivant Sciences Ltd220,126+71.7%$8M1.3%
19DMRA Damora Therapeutics Inc284,430+180.9%$7M1.2%
20AXSM Axsome Therapeutics Inc.28,826+105.1%$7M1.2%
21DFTX Definium Therapeutics Inc148,647+48.8%$7M1.2%
22DNTH Dianthus Therapeutics Inc64,723+19.3%$6M1.0%
23COGT Cogent Biosciences Inc147,510−1.3%$6M0.9%
24ERAS Erasca Inc308,007+38.5%$6M0.9%
25PTGX Protagonist Therapeutics Inc45,400+1035.0%$6M0.9%
26NERV Minerva Neurosciences Inc1.0M+303.0%$6M0.9%
27EDIT Editas Medicine Inc1.3M—$4M0.7%
28CTMX Cytomx Therapeutics Inc.1.1M+192.2%$4M0.7%
29EPRX Eupraxia Pharmaceuticals Inc610,785+40.9%$4M0.7%
30STRO Sutro Biopharma Inc159,118—$4M0.6%
31RLAY Relay Therapeutics Inc178,222−30.9%$3M0.6%
32CLDX Celldex Therapeutics Inc New86,664+195.8%$3M0.5%
33ASND Ascendis Pharma A/S11,869—$3M0.5%
34SGMT Sagimet Biosciences Inc403,545—$3M0.5%
35ZLAB Zai Lab Ltd136,016+74.7%$3M0.5%
36SABS Sab Biotherapeutics Inc736,077+636.1%$3M0.5%
37MDGL Madrigal Pharmaceuticals Inc4,973+46.6%$3M0.4%
38PRAX Praxis Precision Medicines I7,540—$3M0.4%
39RLMD Relmada Therapeutics Inc348,265—$2M0.4%
40AGIO Agios Pharmaceuticals Inc56,900−72.8%$2M0.3%
41XENE Xenon Pharmaceuticals Inc33,300—$2M0.3%
42SVRA Savara Inc309,103+4.5%$2M0.3%
43CCCC C4 Therapeutics Inc381,169+567.8%$2M0.3%
44PCVX Vaxcyte Inc29,800−72.5%$2M0.3%
45CELC Celcuity Inc16,252+170.9%$2M0.3%
46SNDX Syndax Pharmaceuticals Inc77,930—$2M0.3%
47ZNTL Zentalis Pharmaceuticals Inc317,600+188.7%$1M0.2%
48GPCR Structure Therapeutics Inc26,800+197.8%$1M0.2%
49LONA Leonabio Inc154,153−6.4%$1M0.2%
50IDYA Ideaya Biosciences Inc37,865−56.1%$1M0.2%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.